Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Ocean Biomedical, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +3 vs. Q4 2024
- Shares held
- 4.65M
- +969.7K (+26.3%) vs. Q4 2024
- Total value
- $247.3K
- −$1.76M (−87.7%) vs. Q4 2024
- New holders
- 9
- 5 more added
- Sold out
- 6
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCEA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 7 | $5.69K |
| Q1 2025 | 25 | $247.3K |
| Q4 2024 | 22 | $2.01M |
| Q3 2024 | 21 | $3.46M |
| Q2 2024 | 36 | $4.77M |
| Q1 2024 | 46 | $17.1M |
| Q4 2023 | 35 | $3.02M |
| Q3 2023 | 39 | $24.2M |
| Q2 2023 | 35 | $40.6M |
| Q1 2023 | 17 | $47.6M |
| Q4 2022 | 43 | $108.1M |
| Q3 2022 | 40 | $105.9M |
| Q2 2022 | 35 | $102.9M |
| Q1 2022 | 34 | $99.4M |
| Q4 2021 | 26 | $81.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Ocean Biomedical, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 2,688,193 | $142.5K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 473,098 | $25.5K | 0.00% | +433,903+1,107.0% | Added |
| Vanguard Group Inc | 406,529 | $22.0K | 0.00% | 00.0% | Unchanged |
| JustInvest LLC | 260,496 | $14.1K | 0.00% | +260,496 | New |
| UBS Group AG | 246,259 | $13.3K | 0.00% | +191,112+346.6% | Added |
| Geode Capital Management, LLC | 161,571 | $8.73K | 0.00% | −13,737−7.8% | Reduced |
| Susquehanna International Group, LLP | 98,427 | $5.32K | 0.00% | +98,427 | New |
| Revolve Wealth Partners, LLC | 69,570 | $3.76K | 0.00% | +69,570 | New |
| BlackRock, Inc. | 60,499 | $3.27K | 0.00% | −378−0.6% | Reduced |
| State Street Corp | 32,800 | $1.77K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,775 | $1.45K | 0.00% | 00.0% | Unchanged |
| 180 Wealth Advisors, LLC | 25,288 | $1.37K | 0.00% | +25,288 | New |
| Baader Bank INC | 26,796 | $1.14K | 0.00% | +26,796 | New |
| Two Sigma Investments, LP | 19,871 | $1.07K | 0.00% | +19,871 | New |
| Group One Trading, L.P. | 19,002 | $1.03K | 0.00% | +19,002 | New |
| HBK Sorce Advisory LLC | 11,293 | $610 | 0.00% | +11,293 | New |
| EverSource Wealth Advisors, LLC | 5,435 | $293 | 0.00% | +5,435 | New |
| SBI Securities Co., Ltd. | 3,617 | $195 | 0.00% | +3,600+21,176.5% | Added |
| JPMorgan Chase & Co | 233 | $12 | 0.00% | −3−1.3% | Reduced |
| Citigroup Inc | 142 | $8 | 0.00% | −4,658−97.0% | Reduced |
| BNP Paribas Arbitrage, SA | 143 | $8 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 92 | $5 | 0.00% | +5+5.7% | Added |
| Farther Finance Advisors, LLC | 1 | $0 | 0.00% | −182−99.5% | Reduced |
| Simplex Trading, LLC | 12,933 | $0 | 0.00% | +11,378+731.7% | Added |
| FNY Investment Advisers, LLC | 600 | $0 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −124,895−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,450−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| ACT Advisors, LLC. | 0 | $0 | 0.00% | −15,911−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,511−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −792−100.0% | Sold out |